Agenus (AGEN) Misses Q4 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. DRS
5. GS
6. AVAV
7. ACI
8. UNH
9. ORCL
10. DVLT

Go back to Agenus (AGEN) Misses Q4 EPS by 12c

Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

March 14, 2019 8:01 AM EDT

LEXINGTON, Mass., March 14, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, provided a corporate update and reported financial results for the fourth quarter and full year of 2018.

"We are rapidly advancing with the discovery and clinical development of our innovative I-O... More